Publications

February 1, 2025
Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA
Seminars in Arthritis and Rheumatism
January 4, 2025
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury
Clinical Pharmacology & Therapeutics
November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Bone Marrow Transplantation
November 5, 2024
Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid Leukemia
Blood
October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Bone Marrow Transplantation
October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Bone Marrow Transplantation
September 10, 2024
Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease
Radiology
August 15, 2024
Regulatory Pathways for Qualification and Acceptance of Digital Health Technology-Derived Clinical Trial Endpoints: Considerations for Sponsors
Clinical Pharmacology & Therapeutics
August 1, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
JAMA Oncology
July 30, 2024
Data sharing as the foundation of discovery: ADNI and breakthroughs in Alzheimer’s disease
Alzheimer's & Dementia
July 3, 2024
Alzheimer’s Disease Neuroimaging Initiative (ADNI) Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease Project Team
medRxiv
June 24, 2024
Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial
Arthritis Research & Therapy
Show More

Donate

Donate to the FNIH today to support medical research that saves lives

Partner With Us

Work with the FNIH to accelerate medical breakthroughs for patients